Atlas Trials

Individualized Antithrombotic Therapy for Patients With Ischemic Cerebrovascular Disease

Clinical trial NCT03471169 · UNKNOWN

Trial details

NCT number
NCT03471169
Sponsor
Xuanwu Hospital, Beijing
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Cerebrovascular Disease
Start date
2017-04-01
Primary completion
2018-12-01
Enrollment
3500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.